EP1800673 - Nitrophenyls and related compounds and thimerosal for the inhibition of immune related cell or tissue destruction [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 06.02.2009 Database last updated on 03.09.2024 | Most recent event Tooltip | 06.02.2009 | Application deemed to be withdrawn | published on 11.03.2009 [2009/11] | Applicant(s) | For all designated states Canadian Blood Services 1800 Alta Vista Drive Ottawa, Ontario K1G 4J5 / CA | [2007/26] | Inventor(s) | 01 /
Branch, Donald R., c/o Canadian Blood Services 67 College Street, Toronto Ontario M5G 2M1 / CA | 02 /
Lazarus, Alan H., c/o St. Michael's Hospital Shuter Wing, 2-001A, 30 Bond Street Toronto, Ontario M5B 1W8 / CA | 03 /
Crow, Andrew R. c/o St. Michael's Hospital Transfusion Medicine Research RM 2-001 S 30Bond Street Toronto, ON, M5B 1W8 / CA | [2007/51] |
Former [2007/26] | 01 /
Branch, Donald R., c/o Canadian Blood Services 67 College Street, Toronto Ontario M5G 2M1 / CA | ||
02 /
Lazarus, Alan H., c/o St. Michael's Hospital Shuter Wing, 2-001A, 30 Bond Street Toronto, Ontario M5B 1W8 / CA | |||
03 /
Crow, Andrew, c/o Canadian Blood Services 1800 Alta Vista Drive Ottawa, Ontario K1G 4J5 / CA | Representative(s) | Kuhnen & Wacker Patent- und Rechtsanwaltsbüro PartG mbB Prinz-Ludwig-Straße 40A 85354 Freising / DE | [N/P] |
Former [2007/26] | Kuhnen & Wacker Patent- und Rechtsanwaltsbüro Prinz-Ludwig-Strasse 40A 85354 Freising / DE | Application number, filing date | 06026477.7 | 20.12.2006 | [2007/26] | Priority number, date | US20050752912P | 23.12.2005 Original published format: US 752912 P | [2007/26] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | EP1800673 | Date: | 27.06.2007 | Language: | EN | [2007/26] | Type: | A3 Search report | No.: | EP1800673 | Date: | 15.08.2007 | [2007/33] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 18.07.2007 | Classification | IPC: | A61K31/045, A61K31/105, A61K31/305, C07K16/00, A61P7/06, A61P37/00, A61P19/02, A61P21/04 | [2007/26] | CPC: |
A61K31/105 (EP,US);
A61K31/04 (EP,US);
A61K31/045 (EP,US);
A61K31/06 (EP,US);
A61K31/305 (EP,US);
A61K38/39 (EP,US);
A61K39/395 (EP,US);
A61K45/06 (EP,US);
A61P19/02 (EP);
| C-Set: |
A61K31/045, A61K2300/00 (US,EP);
A61K31/04, A61K2300/00 (US,EP);
A61K31/06, A61K2300/00 (EP,US);
A61K31/105, A61K2300/00 (US,EP);
A61K31/305, A61K2300/00 (US,EP);
A61K38/39, A61K2300/00 (EP,US); | Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR [2007/26] | Title | German: | Nitrophenyle und verwandte Zusammensetzungen sowie Thimerosal zur Hemmung von immunspezifischer Zell- oder Gewebezerstörung | [2007/26] | English: | Nitrophenyls and related compounds and thimerosal for the inhibition of immune related cell or tissue destruction | [2007/26] | French: | Nitrophényles et composés associés et thimérosal pour l'inhibition de la destruction cellulaire ou tissulaire liée à l'immunité | [2007/26] | Examination procedure | 16.01.2008 | Examination requested [2008/09] | 11.04.2008 | Despatch of a communication from the examining division (Time limit: M04) | 22.08.2008 | Application deemed to be withdrawn, date of legal effect [2009/11] | 30.09.2008 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2009/11] | Fees paid | Penalty fee | Additional fee for renewal fee | 31.12.2008 | 03   M06   Not yet paid |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X]WO9412163 (ABBOTT LAB [US]) [X] 1,2,7 * page 4, line 20 - page 5, line 16 * * page 8, line 12 - page 10, line 36 * * claims 1,3,4 *; | [X]EP1232748 (MEN TEWA [CN], et al) [X] 1,6-8,18,19,21 * column 1, paragraphs 4-6 * * columns 3-4, paragraph 21 * * column 5, paragraphs 26,27 * * column 6, line 56 - column 7, line 4 * * column 8, paragraphs 31,35 * * column 12, lines 50,51 * * column 12, paragraph 49 - column 13, paragraph 50 * * column 17, lines 7-15 * * column 17, line 46 - column 18, line 3 * * claims 1,6,9,13 *; | [X]WO9925347 (NEUROSEARCH AS [DK], et al) [X] 1,6-8,18-21 * page 5, lines 1-5 * * page 7, lines 7-30 * * page 9, line 21 - page 10, line 4 * * page 20, line 6 - page 21, line 8 * * claims 1,13,16 *; | [X]WO0135955 ; | [X]EP1247818 (ORTHO CLINICAL DIAGNOSTICS INC [US]) [X] 11,17 * page 4, paragraphs 16,17 * * claims 1,3,6-8 *; | [X]GB1546177 (BIOKEMA SA) [X] 11,17 * page 1, lines 9-15 * * page 2, lines 18-24 * * claims 1,7,10,17 *; | [X]WO0162668 (UNIV HEALTH NETWORK [CA], et al) [X] 9 * page 1, lines 8-13 * * page 5, lines 20-38 * * page 7, line 30 * * page 13, line 17 - page 14, line 3 * * page 63, lines 9-13 * * claim 19 *; | [X]US2003144286 (FRENKEL ALEXANDER DAVID [GB], et al) [X] 18-20 * figures 1a,1c,1d,1e,2a,2b,3a,3b * * page 1, paragraph 7 * * page 11, paragraph 123 * * page 14, paragraph 155 - page 15, paragraph 156 * * examples 1-7,15-17,19,21,28,30 * * claims 54,62,66,67 *; | [X]WO9731016 (ARIAD PHARMA INC [US]) [X] 18 * page 2, lines 10-19 * * page 5, lines 6-15 * * page 9, lines 19-21 * * page 9, line 32 - page 10, line 16 *; | [X]JP2004018465 ; | [X]WO2005013947 (UNIVERSITAETSKLINIKUM MUENSTER [DE], et al) [X] 18,19 * page 1, lines 11-16 * * page 32, line 26 - page 33, line 24 * * page 70, line 28 - page 71, line 20 * * claims 1,7,8,10 *; | [X]WO2005117949 (ARES TRADING SA [CH], et al) [X] 18,20 * page 4, lines 1-10 * * page 14, lines 29-34 * * claims 1,25,31 *; | [A]JPS6191382 ; | [DX] - RAMPERSAD GREGORY C ET AL, "Chemical compounds that target thiol-disulfide groups on mononuclear phagocytes inhibit immune mediated phagocytosis of red blood cells", TRANSFUSION (MALDEN), (200503), vol. 45, no. 3, ISSN 0041-1132, pages 384 - 393, XP002428390 [DX] 1,3,5,8,9,11-13,15,17 * abstract * * page 384, column 2, paragraph 1 - page 385, column 1, paragraph 1 * * page 385, column 1, paragraph 4 * * page 385, column 2, paragraph 3 * * figures 1,2,4 * * page 387, column 2, paragraph 2 * * page 388, column 2, paragraph 2 * * page 390, column 2, paragraph 2 - page 391, column 2, paragraph L * DOI: http://dx.doi.org/10.1111/j.1537-2995.2005.04241.x | [X] - BRANCH DONALD R ET AL, "Targeted Interference of Monocyte-Macrophage Membrane Disulfide and Thiol Groups Results in Inhibition of Fc-Receptor Mediated Phagaocytosis of Antibody-Coated Red Cells.", BLOOD, & 44TH ANNUAL MEETING OF THE AMERICAN SOCIETY OF HEMATOLOGY; PHILADELPHIA, PA, USA; DECEMBER 06-10, 2002, (20021116), vol. 100, no. 11, ISSN 0006-4971, page Abstract No. 1084, XP008077342 [X] 5-8,11,17 * the whole document * | [X] - ADACHI Y. ET AL., "Benzene derivatives and use thereof as drugs", DATABASE WPI, 0, Derwent World Patents Index, (20010525), no. 20, Database accession no. 2001389812, page 1, XP002428401 & WO0135955 A 20010525 (TORAY IND INC) [X] 1,2,7 * column A * | [X] - MENG CHARLES Q ET AL, "Nitrobenzene compounds inhibit expression of VCAM-1", BIOORGANIC AND MEDICINAL CHEMISTRY LETTERS, (20010723), vol. 11, no. 14, ISSN 0960-894X, pages 1823 - 1827, XP008080765 [X] 18 * abstract * * table 1 * * page 1824, column 2, paragraph 1 - page 1825, column 2, paragraph 1 * * figures 1-5 * * page 1826, column 1, paragraph 2 * DOI: http://dx.doi.org/10.1016/S0960-894X(01)00306-7 | [X] - KATO F. ET AL., "Cytokine production depressant characterised by selectively controlling IL-5 production", DATABASE WPI, 0, Derwent World Patents Index, (20040122), no. 20, Database accession no. 2004-195480, page 9, XP002441612 & JP2004018465 A 20040122 (ISHIHARA SANGYO KAISHA LTD) [X] 18 * the whole document * | [A] - MURAKAMI ET AL., "Manufacture of 2-(nitrophenyl)ethanols", DATABASE WPI, 0, Derwent World Patents Index, (19860509), no. 19, Database accession no. 1986-158941, page 5, XP002428402 & JPS6191382 A 19860509 (NIPPON KAYAKU KK) [A] 10 * column A * | [A] - HOLDER JAMES W, "Nitrobenzene carcinogenicity in animals and human hazard evaluation", TOXICOLOGY AND INDUSTRIAL HEALTH, (199908), vol. 15, no. 5, ISSN 0748-2337, pages 445 - 457, XP008077336 [A] 1 * abstract * * page 453, column 1, paragraph 3 - column 2, paragraph 1 * * page 454, column 2, paragraph 1 * | [A] - NISTOR CATALIN ET AL, "Competitive flow immunoassay with fluorescence detection for determination of 4-nitrophenol", ANALYTICA CHIMICA ACTA, (20010112), vol. 426, no. 2, ISSN 0003-2670, pages 185 - 195, XP002428391 [A] 1,2 * abstract * * page 185, column 2, paragraph 1 - page 186, column 1, paragraph 1 * DOI: http://dx.doi.org/10.1016/S0003-2670(00)00825-4 | [A] - TSAI W-M ET AL, "INFLUENCE OF FREE THIOL GROUPS ON AUTOANTIBODY-DEFINED EPITOPE OF PROLIFERATING CELL NUCLEAR ANTIGEN", JOURNAL OF IMMUNOLOGY, (1992), vol. 149, no. 6, ISSN 0022-1767, pages 2227 - 2233, XP002441531 [A] 18 * abstract * | [DPX] - FOO ALISON H ET AL, "Structure-function studies for in vitro chemical inhibition of Fc gamma receptor-mediated phagocytosis.", TRANSFUSION FEB 2007, (200702), vol. 47, no. 2, ISSN 0041-1132, pages 290 - 298, XP002428392 [DPX] 1-4,6-10 * abstract * * page 291, column 1, paragraph 2 * * figures 1-3 * * page 293, column 1, paragraph 2 - page 296, column 1, paragraph 1 * * page 296, column 2, paragraph L - page 297, column 1, paragraph L * DOI: http://dx.doi.org/10.1111/j.1537-2995.2007.01105.x |